Georgia-grown cucumbers declared safe amid national recall
The Brief
Georgia-grown cucumbers are not affected by the recent Salmonella-related recall involving Florida-based Bedner Growers Inc., state agriculture officials confirmed.
Some retailers mistakenly canceled orders of safe Georgia-grown cucumbers; the Georgia Department of Agriculture is inspecting stores to ensure recalled Florida products are removed.
Consumers are urged to check for PennRose Farms cucumbers with UPC code 841214101714 and discard recalled products; Georgia-grown produce remains safe and in season.
ATLANTA - Georgia agriculture officials are reassuring consumers that cucumbers grown and sold in Georgia are safe to eat, following a nationwide recall involving Florida-grown cucumbers potentially contaminated with Salmonella.
What we know
Last week, Florida-based Bedner Growers Inc. voluntarily recalled cucumbers distributed from April 29 to May 19 after a Salmonella outbreak sickened at least 26 people in 15 states, including Georgia. Some of the recalled produce was repackaged into 5-pound mesh bags by PennRose Farms, LLC and distributed to Restaurant Depot centers in Florida, Georgia, Illinois, New Jersey, and Ohio.
RELATED: Cucumbers recalled after Salmonella sickens 26 in several states; 9 hospitalized
The Georgia Department of Agriculture confirmed that while some Georgia retailers may have received affected products from the Florida supplier, no Georgia Grown cucumbers or producers are impacted by the recall.
What they're saying
"In light of the Bedner Growers Inc. cucumber recall in Florida, I want to reassure consumers and retailers alike that no Georgia Grown cucumbers or Georgia producers have been impacted," said Georgia Agriculture Commissioner Tyler Harper. "As Georgians head to the stores ahead of the holiday weekend, you can and should have 100% confidence that Georgia Grown cucumbers are safe and wholesome."
Despite this, the Georgia Department of Agriculture has received reports of retailers canceling orders of Georgia-grown cucumbers out of confusion or caution. Inspectors from the department's Food Safety Division are currently visiting stores to ensure any recalled Florida-grown products are removed from shelves.
What you can do
Consumers are urged to check packaging if they recently purchased cucumbers. The recalled PennRose Farms cucumbers were packaged between May 2 and May 5 with the UPC code 841214101714 and lot numbers 48-122 to 48-125. Any consumers in possession of the affected cucumbers are advised not to eat them and to discard the produce immediately.
For more information about the recall, consumers may contact PennRose Farms at 800-804-7254 between 8 a.m. and 5 p.m. EST.
Georgia agriculture leaders encourage residents to continue supporting local farmers during the peak of the spring harvest and to look for the Georgia Grown label when shopping.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Associated Press
44 minutes ago
- Associated Press
A crane collapses kills 2 at a Florida construction site, officials say
MERRITT ISLAND, Fla. (AP) — Two people died Wednesday after a giant crane collapsed at the construction site for a new central Florida hospital, officials said. The collapse occurred at the site of the new Cape Canaveral Hospital in Merritt Island, which is on the Atlantic coast about 60 miles (90 kilometers) east of Orlando. Two people were transported to a nearby hospital, where they later died, Brevard County Sheriff's Office spokesperson Tod Goodyear said. Officials didn't immediately identify the victims. The area had been hit by rain and strong winds Wednesday afternoon, but the exact cause of the collapse was under investigation. The Cape Canaveral Hospital began construction last year and is expected to open to the public in 2027. It will replace the existing Cape Canaveral Hospital in nearby Cocoa Beach.


CBS News
an hour ago
- CBS News
New push to improve access to fertility treatment
In vitro fertilization (IVF) brings hope to families but at a cost many cannot afford. President Donald Trump recently put the issue under a microscope, ordering top leaders to look at ways to make fertility treatments more accessible. The struggle is one Marianett Navarro and her husband Joel Thomas are intimately familiar with. Navarro battled endometriosis for years and that led to a diagnosis of scar tissue blocking her fallopian tubes. "I need to have IVF because the tubes are obstructed, so the process wasn't naturally gonna be there," Navarro explained. That diagnosis brought hope until another setback. Their insurance would not cover IVF. "So, it was a gut punch because we're like, 'Oh, you know, we're good, we're fully insured. We'll figure it out,' but no," Thomas said. IVF cost out of reach for some In vitro fertilization is a common option for couples struggling to conceive. One cycle can cost $15,000 to $20,000, according to the U.S. Department of Health and Human Services. While more employers are offering coverage, 29 states, including Florida, do not require insurance to cover it. For these two South Florida school teachers, the cost felt nearly impossible. "So it wasn't just about, 'Oh we're gonna save money and we're gonna try this'. It was about how we need to find money now, because we're never gonna have a better chance than now," Navarro said. Fertility help for families That's where BabyQuest came in. The California-based nonprofit offers grants to help cover IVF costs for families like Navarro and Thomas. "Not everybody is affected by this, but more people than you can imagine are," Pamela Hirsch, who founded the nonprofit 14 years ago, said. In that time, the group awarded $3.5 million in IVF grants. The American Society for Reproductive Medicine said it's time the financial barriers to fertility treatment get the attention from decision-makers and stakeholders. "I think it's important to know we are not asking for special treatment. We want infertility and other reproductive disorders to be treated like other kinds of medical care," Sean Tipton, chief advocacy and policy officer, said. As for Navarro and Thomas, they're excited to start their IVF journey this summer, thanks to BabyQuest. They hope more families will get the same chance. "I wanna be one of the lucky ones that gets to have a little life and develop that into something great for the world. It's everything," Navarro said. Trump ordered the new IVF plan to be complete in 90 days which landed in mid-May. We reached out to the White House for an update and a spokesperson sent us the following statement: "The Domestic Policy Council has worked closely with external stakeholder groups for nearly three months to deliver on President Trump's executive order to formulate a plan on expanding IVF access for American families. This is a key priority for President Trump, and the Domestic Policy Council has completed its recommendations."
Yahoo
2 hours ago
- Yahoo
CSI Pharmacy Secures California Non-Resident Permit, Achieving Nationwide Reach
Bringing Personalized Specialty Pharmacy Services to All 50 States NASHVILLE, Tenn., June 4, 2025 /PRNewswire/ -- CSI Pharmacy is proud to reveal that, as of May 13, 2025, it is officially licensed to serve patients in all 50 states with the approval of two non-resident California pharmacy permits. This milestone marks a major achievement in CSI Pharmacy's mission to deliver personalized, patient-centered specialty pharmacy care to individuals living with chronic and rare diseases. James Sheets, PharmD, CEO and Founder of CSI Pharmacy, shared his thoughts on the significance of this expansion: "Reaching all 50 states is more than a milestone for us — it's a reflection of our commitment to ensure patients receive the highest level of care and comfort. California is home to one of the most diverse patient populations in the country, and we're excited to deliver our compassionate, personalized care to communities that need it most. At CSI, we believe in 'individualized therapies designed to be as unique as you,' and we're proud to extend that promise to every corner of the nation." With licensure secured, CSI Pharmacy can begin serving California-based patients immediately. Several patient transfers are already in progress, and their team is prepared to onboard additional referrals. To meet growing demand, CSI Pharmacy will expand its team to support this new territory in the coming months. Additionally, CSI Pharmacy is exploring physical space options in the state as well. While this physical location is not required to serve patients, the future brick and mortar expansion represents the passion they hold to serve patients well and quickly. The new licenses not only emphasize CSI Pharmacy's nationwide capabilities, but it also highlights an ongoing commitment to access, equity, and personalized care across every community CSI Pharmacy serves. About CSI PharmacyCSI Pharmacy is a nationwide specialty infusion pharmacy focused on supporting patients with chronic and rare conditions through home-based immunoglobulin (IVIg and SCIg) therapies and other complex medications. The expert team works closely with providers, insurance groups, and advocacy organizations to ensure timely access to life-changing treatments with compassion, precision, and purpose. For more information, visit or contact info@ View original content to download multimedia: SOURCE CSI Pharmacy